UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Ambulatory management of alcohol withdrawal

Authors
Stephen R Holt, MD, MS, FACP
Jeanette M Tetrault, MD, FACP, FASAM
Section Editor
Richard Saitz, MD, MPH, FACP, DFASAM
Deputy Editor
Richard Hermann, MD

INTRODUCTION

Patients with alcohol use disorder may experience a withdrawal syndrome when they abruptly stop or sharply reduce consumption. Mild withdrawal symptoms can include anxiety, agitation, restlessness, insomnia, tremor, diaphoresis, palpitations, headache, and alcohol craving, and often loss of appetite, nausea, and vomiting. Symptoms of more severe withdrawal can additionally include hallucinations as well as seizures or delirium tremens; the latter two can be life-threatening.

Medically supervised alcohol withdrawal is indicated for patients with or at risk of withdrawal symptoms. For patients with mild symptoms and no history of seizures or delirium tremens, supervised withdrawal can be managed safely and effectively in the ambulatory setting. Patients with more severe symptoms and/or at risk of delirium tremens, seizures, or hallucinations require closer monitoring and intervention, typically in an inpatient setting.

This topic reviews ambulatory management of mild alcohol withdrawal. Management of inpatients with moderate to severe withdrawal are reviewed separately. The epidemiology, clinical manifestations, course, assessment, and diagnosis of alcohol withdrawal are also reviewed separately. The epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis of alcohol use disorder are also reviewed separately. (See "Management of moderate and severe alcohol withdrawal syndromes" and "Alcohol withdrawal: Epidemiology, clinical manifestations, course, assessment, and diagnosis" and "Risky drinking and alcohol use disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis".)

APPROACH TO TREATMENT

Assessment — Patients with alcohol use disorder presenting clinically for medically supervised alcohol withdrawal should receive an initial evaluation that includes:  

Substance use history – Questions influencing decision-making regarding supervised withdrawal include (see "Clinical assessment of substance use disorders"):

                     
To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Nov 30, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
References
Top
  1. Sullivan JT, Sykora K, Schneiderman J, et al. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 1989; 84:1353.
  2. Foy A, McKay S, Ling S, et al. Clinical use of a shortened alcohol withdrawal scale in a general hospital. Intern Med J 2006; 36:150.
  3. Schuckit MA, Danko GP, Smith TL, et al. A 5-year prospective evaluation of DSM-IV alcohol dependence with and without a physiological component. Alcohol Clin Exp Res 2003; 27:818.
  4. Goodson CM, Clark BJ, Douglas IS. Predictors of severe alcohol withdrawal syndrome: a systematic review and meta-analysis. Alcohol Clin Exp Res 2014; 38:2664.
  5. Etherington JM. Emergency management of acute alcohol problems. Part 1: Uncomplicated withdrawal. Can Fam Physician 1996; 42:2186.
  6. Amato L, Minozzi S, Vecchi S, Davoli M. Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev 2010; :CD005063.
  7. Myrick H, Malcolm R, Randall PK, et al. A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. Alcohol Clin Exp Res 2009; 33:1582.
  8. Stock CJ, Carpenter L, Ying J, Greene T. Gabapentin versus chlordiazepoxide for outpatient alcohol detoxification treatment. Ann Pharmacother 2013; 47:961.
  9. Whitfield CL, Thompson G, Lamb A, et al. Detoxification of 1,024 alcoholic patients without psychoactive drugs. JAMA 1978; 239:1409.
  10. Asplund CA, Aaronson JW, Aaronson HE. 3 regimens for alcohol withdrawal and detoxification. J Fam Pract 2004; 53:545.
  11. Mirijello A, D'Angelo C, Ferrulli A, et al. Identification and management of alcohol withdrawal syndrome. Drugs 2015; 75:353.
  12. Kaim SC, Klett CJ, Rothfeld B. Treatment of the acute alcohol withdrawal state: a comparison of four drugs. Am J Psychiatry 1969; 125:1640.
  13. Holbrook AM, Crowther R, Lotter A, et al. Meta-analysis of benzodiazepine use in the treatment of acute alcohol withdrawal. CMAJ 1999; 160:649.
  14. Sellers EM, Naranjo CA, Harrison M, et al. Diazepam loading: simplified treatment of alcohol withdrawal. Clin Pharmacol Ther 1983; 34:822.
  15. Wilson A, Vulcano BA. Double-blind trial of alprazolam and chlordiazepoxide in the management of the acute ethanol withdrawal syndrome. Alcohol Clin Exp Res 1985; 9:23.
  16. McKeon A, Frye MA, Delanty N. The alcohol withdrawal syndrome. J Neurol Neurosurg Psychiatry 2008; 79:854.
  17. Schuckit MA. Recognition and management of withdrawal delirium (delirium tremens). N Engl J Med 2014; 371:2109.
  18. Charness ME, Simon RP, Greenberg DA. Ethanol and the nervous system. N Engl J Med 1989; 321:442.
  19. Cook CC. Prevention and treatment of Wernicke-Korsakoff syndrome. Alcohol Alcohol Suppl 2000; 35:19.
  20. Erstad BL, Cotugno CL. Management of alcohol withdrawal. Am J Health Syst Pharm 1995; 52:697.
  21. Hayashida M, Alterman AI, McLellan AT, et al. Comparative effectiveness and costs of inpatient and outpatient detoxification of patients with mild-to-moderate alcohol withdrawal syndrome. N Engl J Med 1989; 320:358.
  22. Soyka M, Horak M. Outpatient alcohol detoxification: implementation efficacy and outcome effectiveness of a model project. Eur Addict Res 2004; 10:180.
  23. Wiseman EJ, Henderson KL, Briggs MJ. Outcomes of patients in a VA ambulatory detoxification program. Psychiatr Serv 1997; 48:200.
  24. Muncie HL Jr, Yasinian Y, Oge' L. Outpatient management of alcohol withdrawal syndrome. Am Fam Physician 2013; 88:589.
  25. Perry EC. Inpatient management of acute alcohol withdrawal syndrome. CNS Drugs 2014; 28:401.
  26. Griffiths RR, Wolf B. Relative abuse liability of different benzodiazepines in drug abusers. J Clin Psychopharmacol 1990; 10:237.
  27. Griffiths RR, Johnson MW. Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds. J Clin Psychiatry 2005; 66 Suppl 9:31.
  28. Collins MN, Burns T, van den Berk PA, Tubman GF. A structured programme for out-patient alcohol detoxification. Br J Psychiatry 1990; 156:871.
  29. https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020235s041,020882s028,021129s027lbl.pdf (Accessed on November 16, 2017).
  30. Feldman DJ, Pattison EM, Sobell LC, et al. Outpatient alcohol detoxification: initial findings on 564 patients. Am J Psychiatry 1975; 132:407.
  31. Abbott PJ, Quinn D, Knox L. Ambulatory medical detoxification for alcohol. Am J Drug Alcohol Abuse 1995; 21:549.
  32. Markowitz JS, Finkenbine R, Myrick H, et al. Gabapentin abuse in a cocaine user: implications for treatment? J Clin Psychopharmacol 1997; 17:423.
  33. Reccoppa L, Malcolm R, Ware M. Gabapentin abuse in inmates with prior history of cocaine dependence. Am J Addict 2004; 13:321.
  34. Victorri-Vigneau C, Guerlais M, Jolliet P. Abuse, dependency and withdrawal with gabapentin: a first case report. Pharmacopsychiatry 2007; 40:43.
  35. Pittenger C, Desan PH. Gabapentin abuse, and delirium tremens upon gabapentin withdrawal. J Clin Psychiatry 2007; 68:483.
  36. Del Paggio D. Psychotropic medication abuse in correctional facilities. Bay Area Psychopharmacology Newsletter 2005; 8:1.
  37. Minozzi S, Amato L, Vecchi S, Davoli M. Anticonvulsants for alcohol withdrawal. Cochrane Database Syst Rev 2010; :CD005064.
  38. Malcolm R, Myrick H, Roberts J, et al. The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial. J Gen Intern Med 2002; 17:349.
  39. Stuppaeck CH, Pycha R, Miller C, et al. Carbamazepine versus oxazepam in the treatment of alcohol withdrawal: a double-blind study. Alcohol Alcohol 1992; 27:153.
  40. Schik G, Wedegaertner FR, Liersch J, et al. Oxcarbazepine versus carbamazepine in the treatment of alcohol withdrawal. Addict Biol 2005; 10:283.
  41. Martinotti G, di Nicola M, Frustaci A, et al. Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial. Addiction 2010; 105:288.
  42. Richter C, Hinzpeter A, Schmidt F, et al. Levetiracetam for the treatment of alcohol withdrawal syndrome: a multicenter, prospective, randomized, placebo-controlled trial. J Clin Psychopharmacol 2010; 30:720.
  43. Müller CA, Schäfer M, Schneider S, et al. Efficacy and safety of levetiracetam for outpatient alcohol detoxification. Pharmacopsychiatry 2010; 43:184.
  44. Youland KM, Miller RF, Mahoney LJ, et al. Levetiracetam as adjunctive therapy for acute alcohol withdrawal syndrome in hospitalized patients. J Clin Psychopharmacol 2014; 34:704.
  45. Lum E, Gorman SK, Slavik RS. Valproic acid management of acute alcohol withdrawal. Ann Pharmacother 2006; 40:441.
  46. Addolorato G, Leggio L, Abenavoli L, et al. Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam. Am J Med 2006; 119:276.e13.
  47. Muzyk AJ, Fowler JA, Norwood DK, Chilipko A. Role of α2-agonists in the treatment of acute alcohol withdrawal. Ann Pharmacother 2011; 45:649.
  48. Liu J, Wang LN. Baclofen for alcohol withdrawal. Cochrane Database Syst Rev 2015; :CD008502.
  49. Leone MA, Vigna-Taglianti F, Avanzi G, et al. Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses. Cochrane Database Syst Rev 2010; :CD006266.
  50. Blondell RD. Ambulatory detoxification of patients with alcohol dependence. Am Fam Physician 2005; 71:495.